Wood LA - Search Results

1

Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Yip SM, Wells C, Moreira R, Wong A, Srinivas S, Beuselinck B, Porta C, Sim HW, Ernst DS, Rini BI, Yuasa T, Basappa NS, Kanesvaran R, Wood LA, Canil C, Kapoor A, Fu SYF, Choueiri TK, Heng DYC. Yip SM, et al. Among authors: wood la. Cancer. 2018 Sep 15;124(18):3677-3683. doi: 10.1002/cncr.31595. Epub 2018 Oct 11. Cancer. 2018. PMID: 30307610 Free article.

2

Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma.

Wood L, Palmer M, Hewitt J, Urtasun R, Bruera E, Rapp E, Thaell JF. Wood L, et al. Br J Cancer. 1998 Feb;77(4):627-31. doi: 10.1038/bjc.1998.100. Br J Cancer. 1998. PMID: 9484821 Free PMC article. Clinical Trial.

3

Outcome of advanced stage low grade follicular lymphomas in a population-based retrospective cohort.

Wood LA, Coupland RW, North SA, Palmer MC. Wood LA, et al. Cancer. 1999 Mar 15;85(6):1361-8. doi: 10.1002/(sici)1097-0142(19990315)85:6<1361::aid-cncr20>3.0.co;2-w. Cancer. 1999. PMID: 10189143

4

A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancer.

Pelley R, Ganapathi R, Wood L, Rybicki L, McLain D, Budd GT, Peereboom D, Olencki T, Bukowski RM. Pelley R, et al. Cancer Chemother Pharmacol. 2000;46(3):251-4. doi: 10.1007/s002800000139. Cancer Chemother Pharmacol. 2000. PMID: 11021744 Clinical Trial.

5

Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma.

Olencki T, Peereboom D, Wood L, Budd GT, Novick A, Finke J, McLain D, Elson P, Bukowski RM. Olencki T, et al. J Cancer Res Clin Oncol. 2001 May;127(5):319-24. doi: 10.1007/s004320000211. J Cancer Res Clin Oncol. 2001. PMID: 11355147 Clinical Trial.

6

Chemotherapy in metastatic gastric cancer: population-based perceptions and practice patterns of medical oncologists.

Wood LA, Fields AL. Wood LA, et al. Br J Cancer. 2004 May 17;90(10):1885-7. doi: 10.1038/sj.bjc.6601802. Br J Cancer. 2004. PMID: 15138466 Free PMC article.

7

Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib.

Tamaskar I, Bukowski R, Elson P, Ioachimescu AG, Wood L, Dreicer R, Mekhail T, Garcia J, Rini BI. Tamaskar I, et al. Ann Oncol. 2008 Feb;19(2):265-8. doi: 10.1093/annonc/mdm483. Epub 2007 Oct 24. Ann Oncol. 2008. PMID: 17962201 Free article.

8

Sunitinib and sorafenib in metastatic renal cell carcinoma patients with renal insufficiency.

Khan G, Golshayan A, Elson P, Wood L, Garcia J, Bukowski R, Rini B. Khan G, et al. Ann Oncol. 2010 Aug;21(8):1618-1622. doi: 10.1093/annonc/mdp603. Epub 2010 Jan 20. Ann Oncol. 2010. PMID: 20089567 Free article.

9

Temsirolimus in VEGF-refractory metastatic renal cell carcinoma.

MacKenzie MJ, Rini BI, Elson P, Schwandt A, Wood L, Trinkhaus M, Bjarnason G, Knox J. MacKenzie MJ, et al. Ann Oncol. 2011 Jan;22(1):145-148. doi: 10.1093/annonc/mdq320. Epub 2010 Jul 1. Ann Oncol. 2011. PMID: 20595449 Free article.

10

Progression-free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy.

Heng DY, Xie W, Bjarnason GA, Vaishampayan U, Tan MH, Knox J, Donskov F, Wood L, Kollmannsberger C, Rini BI, Choueiri TK. Heng DY, et al. Cancer. 2011 Jun 15;117(12):2637-42. doi: 10.1002/cncr.25750. Epub 2010 Nov 18. Cancer. 2011. PMID: 21656741 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page